Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell
Allergan's Strength Lies In Its New Products And Robust Pipeline
Spark Strengthens Case For Hemophilia Gene Therapy (Seeking Alpha)
Related GRMN
Fitbit's Demand Issues Will Take Time To Correct, Needs New Products And Partnerships
14 Stocks That Rallied Four Days, Then Sold Off Yesterday
The Most And Least Loved Stocks In The S&P 500 (Seeking Alpha)

Analysts at Deutsche Bank initiated coverage on Pfizer (NYSE: PFE) with a Buy rating. The target price for Pfizer is set to $34. Pfizer's shares closed at $29.21 yesterday.

Baird initiated coverage on shares of Garmin (NASDAQ: GRMN) with a Neutral rating. The target price for Garmin is set to $59. Garmin's shares closed at $57.46 yesterday.

Analysts at DA Davidson initiated coverage on shares of Oracle (NASDAQ: ORCL) with a Neutral rating. The target price for Oracle is set to $46. Oracle's shares closed at $41.84 yesterday.

Analysts at Jefferies initiated coverage on MannKind (NASDAQ: MNKD) with a Buy rating. The target price for MannKind is set to $10. MannKind's shares closed at $7.34 yesterday.

Latest Ratings for PFE

DateFirmActionFromTo
Dec 2016GuggenheimInitiates Coverage OnNeutral
Nov 2016BarclaysUpgradesEqual-WeightOverweight
Nov 2016BMO CapitalDowngradesOutperformMarket Perform

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (GRMN + MNKD)

View Comments and Join the Discussion!